Cargando…

The Metabolic Syndrome and Microvascular Complications in a Murine Model of Type 2 Diabetes

To define the components of the metabolic syndrome that contribute to diabetic polyneuropathy (DPN) in type 2 diabetes mellitus (T2DM), we treated the BKS db/db mouse, an established murine model of T2DM and the metabolic syndrome, with the thiazolidinedione class drug pioglitazone. Pioglitazone tre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hur, Junguk, Dauch, Jacqueline R., Hinder, Lucy M., Hayes, John M., Backus, Carey, Pennathur, Subramaniam, Kretzler, Matthias, Brosius, Frank C., Feldman, Eva L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2015
Materias:	Complications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542440/ https://www.ncbi.nlm.nih.gov/pubmed/25979075 http://dx.doi.org/10.2337/db15-0133

Ejemplares similares

Transcriptional Profiling of Diabetic Neuropathy in the BKS db/db Mouse: A Model of Type 2 Diabetes
por: Pande, Manjusha, et al.
Publicado: (2011)

Comparative RNA‐Seq transcriptome analyses reveal distinct metabolic pathways in diabetic nerve and kidney disease
por: Hinder, Lucy M., et al.
Publicado: (2017)

Differential Effects of Empagliflozin on Microvascular Complications in Murine Models of Type 1 and Type 2 Diabetes
por: Eid, Stephanie A., et al.
Publicado: (2020)

Transcriptomic analysis of diabetic kidney disease and neuropathy in mouse models of type 1 and type 2 diabetes
por: Elzinga, Sarah E., et al.
Publicado: (2023)

Mitochondrial uncoupling has no effect on microvascular complications in type 2 diabetes
por: Hinder, Lucy M., et al.
Publicado: (2019)

Differential effects of minocycline on microvascular complications in murine models of type 1 and type 2 diabetes
por: Eid, Stephanie A., et al.
Publicado: (2020)

Juvenile murine models of prediabetes and type 2 diabetes develop neuropathy
por: O'Brien, Phillipe D., et al.
Publicado: (2018)

Enhanced Expression of Janus Kinase–Signal Transducer and Activator of Transcription Pathway Members in Human Diabetic Nephropathy
por: Berthier, Celine C., et al.
Publicado: (2009)

mTORC1-Independent Reduction of Retinal Protein Synthesis in Type 1 Diabetes
por: Fort, Patrice E., et al.
Publicado: (2014)

Skin Advanced Glycation End Products Glucosepane and Methylglyoxal Hydroimidazolone Are Independently Associated With Long-term Microvascular Complication Progression of Type 1 Diabetes
por: Genuth, Saul, et al.
Publicado: (2015)

A High-Fat Diet Disrupts Nerve Lipids and Mitochondrial Function in Murine Models of Neuropathy
por: Rumora, Amy E., et al.
Publicado: (2022)

Rho Kinase Inhibition by Fasudil Ameliorates Diabetes-Induced Microvascular Damage
por: Arita, Ryoichi, et al.
Publicado: (2009)

Sex Differences in Coronary Microvascular Function in Individuals With Type 2 Diabetes
por: Haas, Andrea V., et al.
Publicado: (2019)

Dietary reversal of neuropathy in a murine model of prediabetes and metabolic syndrome
por: Hinder, Lucy M., et al.
Publicado: (2017)

Mineralocorticoid Receptor Blockade Improves Coronary Microvascular Function in Individuals With Type 2 Diabetes
por: Garg, Rajesh, et al.
Publicado: (2015)

Plasma Exosomes Contribute to Microvascular Damage in Diabetic Retinopathy by Activating the Classical Complement Pathway
por: Huang, Chao, et al.
Publicado: (2018)

miR-146a–Mediated Extracellular Matrix Protein Production in Chronic Diabetes Complications
por: Feng, Biao, et al.
Publicado: (2011)

Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial
por: Lachin, John M., et al.
Publicado: (2017)

Plasma advanced glycation end products and the subsequent risk of microvascular complications in type 1 diabetes in the DCCT/EDIC
por: Monnier, Vincent M, et al.
Publicado: (2022)

A1C Variability and the Risk of Microvascular Complications in Type 1 Diabetes: Data from the Diabetes Control and Complications Trial
por: Kilpatrick, Eric S., et al.
Publicado: (2008)

The Role of Oxidative Stress in Nervous System Aging
por: Sims-Robinson, Catrina, et al.
Publicado: (2013)

Carbon Monoxide and Nitric Oxide Mediate Cytoskeletal Reorganization in Microvascular Cells via Vasodilator-Stimulated Phosphoprotein Phosphorylation: Evidence for Blunted Responsiveness in Diabetes
por: Li Calzi, Sergio, et al.
Publicado: (2008)

Progression of Carotid Artery Intima-Media Thickness During 12 Years in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study
por: Polak, Joseph F., et al.
Publicado: (2011)

Intravitreal AAV2.COMP-Ang1 Prevents Neurovascular Degeneration in a Murine Model of Diabetic Retinopathy
por: Cahoon, Judd M., et al.
Publicado: (2015)

Lower levels of 25-hydroxyvitamin D(3) are associated with a higher prevalence of microvascular complications in patients with type 2 diabetes
por: Zoppini, Giacomo, et al.
Publicado: (2015)

Impact of C-Peptide Preservation on Metabolic and Clinical Outcomes in the Diabetes Control and Complications Trial
por: Lachin, John M., et al.
Publicado: (2014)

Serum Heat Shock Protein 27 and Diabetes Complications in the EURODIAB Prospective Complications Study : A Novel Circulating Marker for Diabetic Neuropathy
por: Gruden, Gabriella, et al.
Publicado: (2008)

Bcl-2–Modifying Factor Induces Renal Proximal Tubular Cell Apoptosis in Diabetic Mice
por: Lau, Garnet J., et al.
Publicado: (2012)

Improvements in the Life Expectancy of Type 1 Diabetes: The Pittsburgh Epidemiology of Diabetes Complications Study Cohort
por: Miller, Rachel G., et al.
Publicado: (2012)

Toll-Like Receptor 4 Activation Contributes to Diabetic Bladder Dysfunction in a Murine Model of Type 1 Diabetes
por: Szasz, Theodora, et al.
Publicado: (2016)

Podocyte-Specific GLUT4-Deficient Mice Have Fewer and Larger Podocytes and Are Protected From Diabetic Nephropathy
por: Guzman, Johanna, et al.
Publicado: (2014)

REDD1 Ablation Attenuates the Development of Renal Complications in Diabetic Mice
por: Sunilkumar, Siddharth, et al.
Publicado: (2022)

Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease
por: Niewczas, Monika A., et al.
Publicado: (2017)

Metabolic Phenotypes, Vascular Complications, and Premature Deaths in a Population of 4,197 Patients With Type 1 Diabetes
por: Mäkinen, Ville-Petteri, et al.
Publicado: (2008)

Neuronatin: A New Inflammation Gene Expressed on the Aortic Endothelium of Diabetic Mice
por: Mzhavia, Nino, et al.
Publicado: (2008)

Epigenetic Changes in Bone Marrow Progenitor Cells Influence the Inflammatory Phenotype and Alter Wound Healing in Type 2 Diabetes
por: Gallagher, Katherine A., et al.
Publicado: (2015)

Diminished Alveolar Microvascular Reserves in Type 2 Diabetes Reflect Systemic Microangiopathy
por: Chance, William W., et al.
Publicado: (2008)

Uncoupling Endothelial Nitric Oxide Synthase Is Ameliorated by Green Tea in Experimental Diabetes by Re-establishing Tetrahydrobiopterin Levels
por: Faria, Aline M., et al.
Publicado: (2012)

Targeted Lipidomic and Transcriptomic Analysis Identifies Dysregulated Renal Ceramide Metabolism in a Mouse Model of Diabetic Kidney Disease
por: Sas, Kelli M, et al.
Publicado: (2015)

The relationship between symptoms and blood pressure during maintenance hemodialysis
por: Meredith, David J, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ql97du8s5po7ppqgdamuctuhr7